Intas Pharma appoints Ajay Tiwari as President - HR Ruchika Sharma23 Sept 2025 1:30 PM ISTAhmedabad: Intas Pharma has announced the appointment of Ajay Tiwari as President - Human Resources."Throughout his journey, Ajay has been...
Lupin gets 4 USFDA observations for Pune Biotech facility Ruchika Sharma20 Sept 2025 2:45 PM ISTMumbai: Lupin has announced that the company has received four observations from the U.S. Food and Drug Administration (USFDA) after an inspection at...
Lupin Secures CDSCO Panel Clearance for Phase III COPD Inhaler Trial Parthika Patel19 Sept 2025 3:00 PM ISTNew Delhi: Lupin Limited has received recommendations from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization...
Lupin Secures CDSCO Panel Nod for Phase IV Trial of Budesonide-Based COPD Inhaler Parthika Patel18 Sept 2025 6:45 PM ISTNew Delhi: Lupin Limited has received recommendations from the Subject Expert Committee, under the Central Drugs Standard Control Organization (CDSCO)...
Lupin bags USFDA approval for Multiple myeloma treatment Ruchika Sharma17 Sept 2025 6:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...
Lupin gets 6 USFDA observations for Nagpur facility Ruchika Sharma17 Sept 2025 11:00 AM ISTMumbai: Lupin has announced that the U.S. Food and Drugs Administration (USFDA) has closed the inspection with six observations at the company's...
Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, Brazil Ruchika Sharma15 Sept 2025 5:13 PM ISTLupin Manufacturing Solutions has announced that Empagliflozin API, manufactured at its Vizag facility, has received CADIFA approval from ANVISA,...
Lupin gets 2 USFDA observations for Aurangabad facility Ruchika Sharma6 Sept 2025 11:21 AM ISTMumbai: Lupin has received two observations from the U.S. Food and Drug Administration (USFDA) at the closure of an inspection at the Company's...
Lupin wins USFDA nod for Risperidone for extended-release injectable suspension for schizophrenia Ruchika Sharma3 Sept 2025 2:30 PM ISTThis is Lupin's first product using proprietary Nanomi B.V.'s technology and has a 180-day CGT exclusivity.
Lupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made Mandatory Susmita Roy1 Sept 2025 4:23 PM ISTNew Delhi: Lupin has got approval from the Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), to conduct a...
Lincoln Pharma appoints Raja Karunanidhi Nagarajan as Senior General Manager-RnD Ruchika Sharma30 Aug 2025 11:30 AM ISTAhmedabad: Lincoln Pharma has announced the appointment of Raja Karunanidhi Nagarajan as Senior General Manager- Research & Development...
Lupin, Natco Launch Bosentan Tablets in US With 180-Day Exclusivity Parthika Patel20 Aug 2025 2:38 PM ISTMumbai: Global pharma major Lupin Limited on Wednesday announced the launch of Bosentan Tablets for Oral Suspension, 32 mg in the United States, with...
